Tesamorelin Procurement Checklist | Titan Core

A strong procurement decision is a chain of matched facts. The product page, label, lot, certificate, order terms and support response should all describe the same material without contradiction.

For Tesamorelin, that discipline is especially important because the scientific name also appears in an approved prescription-drug context. A research supplier must not blur those categories.

Product-page check

Confirm that the intended Titan Core Tesamorelin page:

loads at its own stable URL;
names and shows the exact offered item;
states research-only restrictions prominently;
avoids medical, dosing and personal-use claims;
describes current availability accurately;
links or explains current documentation; and
offers a working support route.

The route redirected to the homepage during the 14 August 2026 audit, so the CTA and article remain on hold until the route is corrected.

Lot and label check

Capture the lot or batch identifier expected to ship. The same identifier should appear on the physical label and the analytical record presented for the lot. Also review product name, stated amount or format, supplier identity and any storage statement.

If the label cannot be connected to the document, the evidence chain is incomplete.

Certificate check

Review the full report, not a cropped result. Look for:

laboratory identity;
sample and report identifiers;
sample receipt and test dates when provided;
named method;
measured result with units;
signatures or authorization status;
page count and attachments; and
revision status.

Ask whether the supplier can provide the current controlled copy. A social image that says “tested” is not a substitute for a readable report.

Analytical-scope check

Write down the question each method answers. HPLC may report chromatographic purity under stated conditions. Mass spectrometry may support an identity assessment based on detected mass. Neither automatically answers every question about quantity, sterility, endotoxin, residual solvents or experimental suitability.

Use the purity percentage guide to prevent a single percentage from becoming an all-purpose quality claim.

Regulatory and institutional check

Determine whether the proposed work, buyer, destination and material are permitted. Internal biosafety, legal, ethics, procurement or quality review may be required. The buyer remains responsible for institution-specific approval.

The existence of an FDA-approved drug containing tesamorelin does not approve or validate a research-use material sold by another supplier.

Commercial check

Before payment, confirm:

current price and product format;
inventory status;
shipping destination eligibility;
estimated fulfillment timing;
issue, return and replacement terms;
payment confirmation; and
the record-retention owner on the buyer's side.

Keep dated copies of the page, order confirmation and documents used for approval.

Receipt check

When an order arrives, compare the item with the approved record:

supplier and product name;
lot or batch identifier;
label condition and package integrity;
quantity or unit count;
included records; and
visible discrepancy or transit issue.

Quarantine or hold the material under the buyer's procedure if a critical mismatch appears. Contact the supplier with photographs and identifiers, not a vague summary.

The Titan Core standard

“Strength Starts at the Core” means the evidence path should be strong before the sales claim is strong. Titan Core's responsibility is to present the item, boundary, records and support path clearly. The buyer's responsibility is to evaluate them for the proposed work.

Review Tesamorelin

After legal approval, route repair and current lot-document QA, qualified readers may review the intended Titan Core Tesamorelin page. For a pre-order documentation question, contact Titan Core.

Sources and further reading

For qualified research procurement only. This article is not medical advice and does not support personal use.